Budesonide And Formoterol Fumarate Dihydrate Aerosol
Product Images NDC 0310-7372

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Budesonide And Formoterol Fumarate Dihydrate (NDC 0310-7372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Counter Image 15 (308708 Rapihaler Counter 15 (black;130;485))

FDA Label Image

Counter Image 80 (308710 Rapihaler Counter 80 (black;130;485))

FDA Label Image

Figure 1 (Figure1bodytext)

This appears to be a medical document containing a table of numbers, with titles including "Treatment" and various medication names and doses. One medication mentioned is Budesonide and Formoterol Fumarate Dihydrate, with recommended dosages listed.*

FDA Label Image

Figure 2 (Figure2bodytext)

FDA Label Image

Figure 3 (Figure3bodytext)

FDA Label Image

Figure 4 (Figure4bodytext)

This is a graph that shows the percent change from baseline in FEV (Forced Expiratory Volume) over 12 hours. It includes data for 12 hours on day 1 of a study using Budesonide and Formoterol Fumarate Dihydrate inhalations for treatment. The data points are shown at multiple time intervals, marked on the x-axis in hours. The graph also includes a placebo measurement, marked as 'A Placebo' in the Predose FEV column.*

FDA Label Image

Figure 5 (Figure5bodytext)

FDA Label Image

Figure 6 (Figure6bodytext)

This text provides data on the percent change from baseline in pre-dose FEV (forced expiratory volume) for various treatments involving Budesonide and Formoterol Fumarate Dihydrate MDI, with dosage and inhalation frequency specified. The data includes numerical values for each treatment and a placebo control.*

FDA Label Image

Figure 7 (Figure7bodytext)

This is a table showing the percent change from baseline in 1-hour post-dose FEV with different inhalations of Budesonide and Formoterol Fumarate Dihydrate, Budesonide, Formoterol, Budesonide + Formoterol, and Placebo over a 6-months period. The text also includes the dosages and frequencies for each inhalation.*

FDA Label Image

Budesonide Structural Formula (Image 01)

FDA Label Image

Structural Fumarate (Image 02)

FDA Label Image

Figure 1 (Image 03)

This text is a diagram or image labeling related to a counter with a canister inside containing water, a mouthpiece with a strap, and a mouthpiece cover.*

FDA Label Image

Figure 2 Gray Arrows (Image 04)

FDA Label Image

Figure 3 (Image 05)

FDA Label Image

Figure 4 (Image 06)

FDA Label Image

Figure 5 (Image 07)

FDA Label Image

Symbicort Ag 80/4.5 Mcg 120 Inhalations Carton (Image 10)

This is a description of a medication called Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol. The medication comes in a canister with 120 inhalations and has the NDC code 0310-7372:20.*

FDA Label Image

Symbicort Ag 160/4.5 Mcg 120 Inhalations Carton (Image 11)

This is a description of a medication with the name "Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol 160/4.5". It consists of Budesonide and Formoterol Fumarate Dihydrate in the ratio of 160 mcg and 4.5 mcg respectively. One container has 120 inhalations and is meant for oral inhalation only. It is a prescription medicine produced in France by AstraZeneca. Its NDC number is 0310-7376-20.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.